<SEC-DOCUMENT>0001193125-15-329003-index.html : 20150925
<SEC-HEADER>0001193125-15-329003.hdr.sgml : 20150925
<ACCEPTANCE-DATETIME>20150925153011
ACCESSION NUMBER:		0001193125-15-329003
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20150925
DATE AS OF CHANGE:		20150925

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics AG
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89113
		FILM NUMBER:		151125149

	BUSINESS ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
		BUSINESS PHONE:		43 (0)1 740 93-0

	MAIL ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vivo Capital VIII, LLC
		CENTRAL INDEX KEY:			0001618789
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		575 HIGH STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94301
		BUSINESS PHONE:		650 688 0818

	MAIL ADDRESS:	
		STREET 1:		575 HIGH STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94301
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>d60588dsc13g.htm
<DESCRIPTION>SCHEDULE 13G
<TEXT>
Document 1 - file: d60588dsc13g.htm

</DOCUMENT>
</SEC-DOCUMENT>